Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

Severe cases of coronavirus disease 2019 (COVID-19) managed in the intensive care unit
are prone to complications, including secondary infections with opportunistic fungal …

Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …

The effect of corticosteroid therapy is still controversial on prevention of mortality in
coronavirus disease‐2019 (COVID‐19). The objective of this study is to investigate the effect …

Background COVID-19's pulmonary manifestations are broad, ranging from pneumonia with
no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with …

Background: Invasive Fungal Infections (IFI) are emergent complications of COVID-19. In
this study, we aim to describe the prevalence, related factors, and outcomes of IFI in critical …

Patients with severe COVID-19 belong to a population at high risk of invasive fungal
infections (IFIs), with a reported incidence of IFIs in critically ill COVID-19 patients ranging …

Based on the recent reports, cardiovascular events encompass a large portion of the
mortality caused by the COVID‐19 pandemic, which drawn cardiologists into the …

Since the publication of the RECOVERY trial, the use of glucocorticoid drugs (GC) has
spread for the treatment of severe COVID-19 worldwide. However, the benefit of …